Delivra Health BrandsDHBUF Current Ratio is 3.29 as of Mar. 2026, which is 70% above its 10-year median of 1.93. The stock has 3 warning signs investors should review. Among 996 Drug Manufacturers companies, Delivra Health Brands ranks better than 70.38% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Delivra Health Brands's current ratio for the quarter that ended in Mar. 2026 was 3.29.
Delivra Health Brands has a current ratio of 3.29. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Delivra Health Brands's Current Ratio or its related term are showing as below:
DHBUF'
s Current Ratio Range Over the Past 10 Years
Min: 0.5 Med: 1.93 Max: 54.02
Current: 3.29
During the past 13 years, Delivra Health Brands's highest Current Ratio was 54.02. The lowest was 0.50. And the median was 1.93.
DHBUF's Current Ratio is ranked better than 70.38% of 996
companies
in the Drug Manufacturers industry
Industry Median: 2
vs DHBUF: 3.29
Delivra Health Brands (OTCPK:DHBUF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Delivra Health Brands Current Ratio Related Terms
Delivra Health Brands Current Ratio Historical Data
* Premium members only.
The historical data trend for Delivra Health Brands's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delivra Health Brands Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's Current Ratio distribution charts can be found below:
* The bar in red indicates where Delivra Health Brands's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delivra Health Brands (DHBUF) has a Current Ratio of 3.29 as of Mar. 2026. This is 70% above median its historical median of 1.93. Over the past decade, Delivra Health Brands' Current Ratio has ranged from 0.50 to 54.02. According to the industry distribution chart, Delivra Health Brands ranks #295 out of 996 companies in the Drug Manufacturers industry, placing it in the top 29.6%.
Is Delivra Health Brands' Current Ratio too high?
Delivra Health Brands' current Current Ratio of 3.29 is 70% above median its 10-year median of 1.93. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 54.02. The Drug Manufacturers industry median Current Ratio is 2.00. Delivra Health Brands' value of 3.29 is 64.5% above this industry median. Based on the distribution chart, Delivra Health Brands ranks #295 out of 996 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Delivra Health Brands' Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Delivra Health Brands ranks #295 out of 996 companies for Current Ratio. This puts Delivra Health Brands in the upper half of its industry. The industry median Current Ratio is 2.00. Delivra Health Brands' value of 3.29 is 64.5% above this benchmark. Historically, Delivra Health Brands' own Current Ratio has ranged from 0.50 to 54.02 over the past decade. While the company's 10-year median is 1.93 vs. the industry median of 2.00, Delivra Health Brands has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Delivra Health Brands's current Current Ratio of 3.29 is 64.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delivra Health Brands's current Current Ratio is 3.29, which is 70% above median its own 10-year median of 1.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delivra Health Brands stock overvalued right now?
Based on GuruFocus' analysis, Delivra Health Brands (DHBUF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.19, compared to a current price of $0.07 — trading 62.7% below its estimated fair value. The current Current Ratio is 3.29, which is 70% above median its 10-year median of 1.93 and 64.5% above the Drug Manufacturers industry median of 2.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Delivra Health Brands (DHBUF), the current Current Ratio is 3.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHBUF has been successfully added to your 